Song Li mostly deals with Molecular biology, In vivo, Gene delivery, Cancer research and Genetic transfer. His work deals with themes such as Cationic liposome, Hepatocyte nuclear factor 4, microRNA, Proinflammatory cytokine and Gene targeting, which intersect with Molecular biology. His work in In vivo is not limited to one particular discipline; it also encompasses Pharmacology.
His work on Nanocarriers as part of general Pharmacology research is frequently linked to PEG ratio, thereby connecting diverse disciplines of science. His work in Gene delivery tackles topics such as Liposome which are related to areas like Drug carrier. His Cancer research research incorporates themes from Carcinogenesis, Immunology, Immune system, Receptor and CpG site.
Song Li spends much of his time researching Cancer research, Pharmacology, In vivo, Molecular biology and Micelle. His Cancer research study combines topics from a wide range of disciplines, such as Immunology, Cancer, Immune system, Immunotherapy and Cytotoxic T cell. His Pharmacology study incorporates themes from Cancer cell, Biodistribution and Doxorubicin.
As a part of the same scientific family, he mostly works in the field of In vivo, focusing on Liposome and, on occasion, Gene delivery and DNA. His Molecular biology research also works with subjects such as
Cancer research, Vitiligo, Doxorubicin, In vivo and Oxidative stress are his primary areas of study. His research in Cancer research intersects with topics in Cancer, Metastasis, Immune system, Immunotherapy and Combination therapy. His Doxorubicin research incorporates elements of Micelle, Transfection, Prodrug, Pharmacology and Cytotoxicity.
His Transfection research is multidisciplinary, relying on both Nucleic acid and Genetic enhancement. His Paclitaxel research extends to the thematically linked field of In vivo. In his study, which falls under the umbrella issue of Nanocarriers, Liposome is strongly linked to Drug carrier.
His primary areas of investigation include Doxorubicin, Cancer research, Pharmacology, Prodrug and In vivo. His Doxorubicin study combines topics in areas such as Cytotoxicity and Immunotherapy. He has included themes like Cancer, Protein kinase B, In vitro, Mitochondrial ROS and Regulation of gene expression in his Cancer research study.
In the subject of general Pharmacology, his work in Drug is often linked to Total body irradiation, thereby combining diverse domains of study. The In vivo study combines topics in areas such as Ethylene glycol, Biophysics and Nanocarriers. His studies in Nanocarriers integrate themes in fields like Paclitaxel and Drug carrier.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nonviral gene therapy: promises and challenges.
S Li;L Huang.
Gene Therapy (2000)
Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis
Jie Zhou;Maria Febbraio;Taira Wada;Yonggong Zhai.
Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery.
S Li;M A Rizzo;S Bhattacharya;L Huang.
Gene Therapy (1998)
Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection.
Li S;Tseng Wc;Stolz Db;Wu Sp.
Gene Therapy (1999)
Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors
Song Li;Su Ping Wu;Mark Whitmore;Eric J. Loeffert.
American Journal of Physiology-lung Cellular and Molecular Physiology (1999)
Cationic lipids enhance siRNA-mediated interferon response in mice
Zheng Ma;Jiang Li;Fengtian He;Annette Wilson.
Biochemical and Biophysical Research Communications (2005)
Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells.
Rajkumar Banerjee;Pradeep Tyagi;Song Li;Leaf Huang.
International Journal of Cancer (2004)
The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo.
Yadi Tan;Song Li;Bruce R. Pitt;Leaf Huang.
Human Gene Therapy (1999)
lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer
Zehua Wang;Bo Yang;Min Zhang;Weiwei Guo.
Cancer Cell (2018)
Lyophilization of cationic lipid–protamine–DNA (LPD) complexes
Bei Li;Song Li;Yadi Tan;Donna B. Stolz.
Journal of Pharmaceutical Sciences (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: